Proliferation and DNA fragmentation in meningioma subtypes

Neuropathology and Applied Neurobiology

Volumn 23, Issue 6, 1997, Pages 496-506

  Maier, H ^a,c,d   Wanschitz, J ^a   Sedivy, R ^b   Rosslert K ^b   Ofner D ^c   Budka, H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

Apoptosis; BCL 2; Immunohistochemistry; In situ tailing; Ki 67; Meningiomas

Indexed keywords

DNA FRAGMENT; MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 2;

ANAPLASTIC CARCINOMA; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME ASSAY; FROZEN SECTION; GEL ELECTROPHORESIS; HEMANGIOPERICYTOMA; HUMAN; HUMAN TISSUE; LABELING INDEX; MAJOR CLINICAL STUDY; MALIGNANT MENINGIOMA; MENINGIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031474874     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1997.tb01327.x     Document Type: Article

References (63)

1. Ansari B, Coutes PJ, Greenstein BD, Hall PA. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993; 170: 1-8
2. Arends MJ, Morris RG, Wyllie AH. Apoptosis: the role of endonuclease. Am J Pathol 1990; 136: 593-608
3. Askew DS, Ashmun RA, Simmons BC, Cleveland JL. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppreses cell cycle arrest and accelerates apoptosis. Oncogene 1991; 6: 1915-22
4. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992; 359: 552-4
5. Borner C. Diminished cell proliferation associated with the death-protective activity of Bcl-2. J Biol Chem 1996; 271: 12695-8
6. Cattoretti G, Becker MHG, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357-63
7. Cohen JJ. Programmed cell death in the immune system. Adv Immunol 1991; 50: 55-85
8. Colotta F, Polentarutti N, Sironi M, Mantovani A. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 1992; 267: 18278-83
9. Cotter TG, Lennon SV, Glynn JG, Martin SJ. Cell death vis apoptosis and its relationship to growth. Development and differentiation of both tumour and normal cells. Anticancer Res 1990; 10: 1153-60
10. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13: 795-808
11. Duke RC, Chervenak R, Cohen JJ. Endogenous endonuclease-induced DNA fragmentation: an early event in cell mediated cytolysis. Proc Natl Acad Sci USA 1983; 80: 6361-5
12. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-28
13. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992; 359: 554-6
14. Fehsel K, Kolb-Bachofen V, Kolb H. Analysis of TNF-induced DNA strand breaks at the single cell level. Am J Pathol 1991; 139: 251-4
15. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501
16. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20
17. Gerdes J, Becker MHG, Key G, Cattoretti G. Immunohistochemical detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues (letter to the editor). J Pathol 1992; 168: 85-6
18. Glücksmann A. Cell deaths in normal vertebrate ontogeny. Biol Rev Camb Philos Soc 1951; 26: 59-86
19. Gold R, Schmied M, Rothe G, Zischler H, Breitschopf H, Wekerle H, Lassmann H. Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections. J Histochem Cytochem 1993; 41: 1023-30
20. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994; 71: 219-25
21. Hockenbery D. Defining apoptosis. Am J Pathol 1995; 146: 16-9
22. Hockenbery DM, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. BCL-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 548: 334-6
23. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. BCL-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 15: 6961-5
24. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer S. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-51
25. Hsu DW, Pardo FS, Efird JT, Linggood RM, Hedley-Whyte ET. Prognostic significance of proliferative indices in meningiomas. J Neuropathol Exp Neurol 1994; 53: 247-55
26. Ide M, Jimbo M, Yamamoto M, Umebara Y, Hagiwara S, Kubo O. MIB-1 staining index and peritumoral brain edema of meningiomas. Cancer 1996; 78: 133-43
27. Iseki S. DNA strand breaks in rat tissues as detected by in situ nick translation. Exp Cell Res 1986; 167: 511-26
28. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993; 361: 365-9
29. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T. Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB1 monoclonal antibody on archival material. Acta Neuropathol 1994; 87: 47-54
30. Kepes JJ. Meningiomas. Biology, Pathology and Differential Diagnosis. New York: Masson, 1982
31. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57
32. Kerr JFR, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73: 2013-26
33. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. Berlin: Springer. 1993
34. Kokunai T, Sawa H, Tamaki N. Localization of apoptotic cells in situ of brain tumors. Nashuo Byori 1995; 12: 15-21
35. Kolles H, Niedermayer I, Schmitt C, Henn W, Feld R, Steudel WI, Zang KD, Feiden W. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Wien) 1995; 137: 174-81
36. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80: 879-86
37. Kruskal KH, Wallis WA. Use of ranks in the one-criterian variance analysis. J Amer Statist Assoc 1952; 47: 583-621
38. Langford LA, Cooksley CS, DeMonte F. Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Hum Pathol 1996; 27: 350-4
39. Ludwin SK, Rubinstein LJ, Russell DS. Papillary meningioma: a malignant variant of meningioma. Cancer 1975; 36: 1363-73
40. Maier H, Öfner D, Hittmair A, Kitz K, Budka H. Classic, atypical and anaplastic meningiomas: three histopathological subtypes of clinical relevance. J Neurosurg 1992; 77: 616-23
41. Maier H, Öfner D, Budka H. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence (letter). Cancer 1995; 75: 130-1
42. Maier H, Jones C, Jasani B, Öfner D, Zelger B, Schmid KW, Budka H. Metallothionein overexpression in human brain tumours. Acta Neuropathol, in press
43. Majno G, Joris I. Apoptosis oncosis and necrosis. An overview of cell death. Am J Pathol 1995; 146: 3-15
44. Migheli A, Cavalla P, Marino S, Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol 1994; 53: 606-16
45. Mosnier J-F, Perret AG, Brunon J, Boucheron S. Expression of the bcl-2 oncoprotein in meningiomas. Am J Clin Pathol 1996; 106: 652-9
46. Nakagawa S, Shiraishi T, Kihara S, Tabuchi K. Detection of DNA strand breaks associated with apoptosis in human brain tumors. Virchows Arch 1995; 427: 175-9
47. Nakasu S, Nakasu Y, Nioka H, Nakajima M, Hansa J. bcl-2 protein expression in tumors of the central nervous system. Acta Neuropathol 1994; 88: 520-6
48. Nemenyi P. Distribution-free Multiple Comparisons. .State University of New York, Downstate Medical Center, 1963
49. Oka H, Satoh Y, Kawano N, Yagishita S, Kameya T. Expression of BCL-2 gene product in embryonal tumors of the central nervous system. Surg Neurol 1996; 45: 230-5
50. Pasquier B, Gasnier F, Pasquier D, Keddari E, Morens Annie Couderc P. Papillary meningioma. Clinicopathological study of seven cases and review of the literature. Cancer 1986; 58: 299-305
51. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1-6
52. Saunders JW. Death in embryonic systems. Science 1966; 154: 604-178
53. Schiffer D, Fabiani A, Monticone GF, Cognazzo A. On the nature of the lymphocyte-like cells of medulloblastomata. Acta Neuropathol 1966; 6: 290-7
54. Schiffer D, Cavalla P, Chio A, Giordana MT, Marino S, Mauro A, Migheli A. Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol 1994; 87: 362-70
55. Schiffer D, Cavalla P, Migheli A, Chiò A, Giordana MT, Marino S, Attanasio A. Apoptosis and cell proliferation in human neuroepithelial tumors. Neurosci Lett 1995; 195: 81-4
56. Schiffer D, Cavalla P, Migheli A, Giordana MT, Chiado-Piat L. Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study. J Neurooncol 1996; 27: 101-9
57. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992; 89: 4495-9
58. Striepecke E, Handt S, Weis J, Koch A, Cremerius U, Reineke T, Büll U, Schröder JM, Zang KD, Böcking A. Correlation of histology, cytogenetics and proliferation fraction (Ki-67 and PCNA) quantitated by image analysis in meningiomas. Path Res Pract 1996; 192: 816-24
59. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986; 83: 5214-8
60. Wijsman JH, Jonker RR, Keijzer R, van de Velde CJH, Cornelisse CJ, van Dierendonck JH. A new method to detect apoptosis in paraftin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993; 41: 7-12
61. Wilkinson L. systat: The system of statistics. Evanstom, IL. Systat Inc., 1989
62. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-6
63. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345-7